FDA approves radical treatment for knee arthritis to ‘freeze’ cells and ease chronic pain

Posted 13 Jun, 2017 [ssba]

The FDA has given the green light to a new treatment that will ease the pain of knee arthritis for people who can’t have surgery.

Newly approved ‘Coolief’ is a non-invasive procedure that uses radio frequency to freeze nerve cells to stop them from transmitting pain signals to the brain.

Although it doesn’t cure osteoarthritis, it offers an alternative treatment to patients who can’t have a knee replacement surgery.

The new technique can alleviate the debilitating pain for up to a year, an improvement from steroid injections which normally last up to 12 weeks.

The FDA’s approval comes after a study in February 2016  found that 74 percent of patients who had the treatment said their symptoms were at least reduced by half at six months.

At the 12-month mark, 65 percent said their pain was still reduced by half.

Please click the link below to read further:

http://www.dailymail.co.uk/health/article-4600228/New-arthritis-treatment-uses-radio-frequency-ease-pain.html

 

Have a question? Or would like to book in with us?

Get in Touch

Common Conditions
that we Treat Everyday

View All Conditions

Latest from the Blog

Posted 04 Oct, 2019

How To Prevent Headaches And Migraines During Pregnancy

Have you noticed an increase in your migraines and headaches since you became pregnant? Are you worried that they may be the result of some other underlying problem? Many pregnant women will suffer from migraines and headaches during their pregnancy. The increased hormone levels can even cause these headaches to be of...
Posted 07 Feb, 2019

Stellate Ganglion Block a Potential Lifesaver in Severe PTSD

Case reports are mounting of immediate, durable, and significant relief of severe refractory symptoms of posttraumatic stress disorder (PTSD), according to an anesthesiologist who has seen the benefits firsthand. Stellate ganglion blockade (SGB) “seems to significantly improve PTSD symptoms as well as significant...